Similares a 88% Culture Conversion in MAC Lung Disease—Is Earlier ALIS the Answer? | #ats2026

20 vecinos (text_768) · 909 views · HCPLive · Estados Unidos


★	88% Culture Conversion in MAC Lung Disease—Is Earlier ALIS the Answer? \| #ats2026	HCPLive @hcplivenews	909	Estados Unidos
17	Artists Have Higher Rates Of This Illness	Doctor Mike Clips @doctormike2	4.9K	Estados Unidos	82
12	Complex Double Lung Transplant Surgery A Success at Newark Beth Israel Medical Center	RWJBarnabas Health @rwjbarnabashealth	2.6K	Estados Unidos	83
10	Treatment of NTM	National Jewish Health @nationaljewishhealth	2.3K	Estados Unidos	83
15	Mepolizumab Add-On Reduces COPD Exacerbations in Triple-Therapy Patients \| ATS 2026	HCPLive @hcplivenews	1.2K	Estados Unidos	83
5	Patient with Kartagener Syndrome Gets Lung Transplant at Newark Beth Israel Medical Center	RWJBarnabas Health @rwjbarnabashealth	954	Estados Unidos	84
6	Treatment of NTM	National Jewish Health @nationaljewishhealth	771	Estados Unidos	84
14	Detecting Lung Cancer Earlier With AI w/ Prashant Warier, Founder & CEO, Qure.ai	CareTalk: Healthcare. Unfiltered. Podcast @caretalkpodcast	730	Estados Unidos	83
19	Efdoralprin Alfa Normalizes Alpha-1 Antitrypsin Levels I #ats2026	HCPLive @hcplivenews	548	Estados Unidos	82
18	What #Allergists Should Know About Broncho-Vaxom for Respiratory Tract Infection	HCPLive @hcplivenews	348	Estados Unidos	82
8	Ask the Expert Pulmonology Edition featuring Robert Hallowell, MD	The Myositis Association (TMA) @myositisassociation	241	Estados Unidos	83
11	How Robotic Surgery Is Changing Lung Cancer Care	University of Maryland Medical System @universityofmarylandmedica3585	143	Estados Unidos	83
20	REACH Study: Broncho-Vaxom (OM-85) Cuts Recurrent Respiratory Tract Infections	HCPLive @hcplivenews	134	Estados Unidos	82
1	Phase 3b ENCORE: ALIS Improves MAC Lung Disease Outcomes \| ATS 2026	HCPLive @hcplivenews	117	Estados Unidos	93
7	AERIFY: Phase 3 Data Reveal Challenges, Potential of Itepekimab in COPD	HCPLive @hcplivenews	105	Estados Unidos	83
16	Cap 4x13: Teràpia de fags	Universitat de València @universitatvalencia	83	España	82
13	Efdoralprin Alfa vs Standard of Care in AATD: Phase 2 ElevAATe Results	HCPLive @hcplivenews	82	Estados Unidos	83
9	Dupilumab Doubled Asthma Remission Odds in Type 2 Asthma:	HCPLive @hcplivenews	71	Estados Unidos	83
2	ATS 2026 Pulmonology: AD109, Ralinepag, ALIS, Itepekimab & More \| HCPLive Expert Interviews	HCPLive @hcplivenews	55	Estados Unidos	87
4	Emerging Data in NTM Lung Disease: Potential Impacts and Ongoing Challenges	ReachMD @reachmd	7	Estados Unidos	84
3	Early Recognition and Diagnostic Confidence in NTM Lung Disease	ReachMD @reachmd	6	Estados Unidos	84